XML 27 R16.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related-Party Transactions
3 Months Ended
Mar. 31, 2024
Related Party Transactions [Abstract]  
Related-Party Transactions Related-Party Transactions
The Company has outstanding licensing and scientific research agreements with Penn, a significant stockholder as of March 31, 2023 (Note 7). As of December 31, 2023, Penn was no longer a significant stockholder. The Company recognized $0.4 million of research and development expenses for the three months ended March 31, 2023 related to the Penn License Agreement.
The Company has a collaboration and license agreement with Moderna, a significant stockholder (Note 11).